drugset / Trial / NCT05897658
Levetiracetam Prophylaxis in Brain Tumor Resection Pilot
Phase 3
Not yet recruiting
70 enrolled
Hamilton Health Sciences Corporation
McMaster University · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study aims to evaluate feasibility of a double-blind randomized controlled trial for levetiracetam prophylaxis for prevention of seizure in the perioperative phase of brain tumor resection.
Timeline
- Start
- 2025-03
- Primary completion
- 2026-03
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levetiracetam | Other / unclassified | 1 g | Oral |